ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 92 filers reported holding ASCENDIS PHARMA A/S in Q1 2018. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $54,521,000 | -58.4% | 473,475 | -63.9% | 1.25% | -66.2% |
| Q1 2019 | $131,064,000 | +107.9% | 1,313,328 | +24.8% | 3.70% | +54.1% |
| Q4 2018 | $63,043,000 | -17.1% | 1,052,647 | -1.9% | 2.40% | +18.1% |
| Q3 2018 | $76,008,000 | +6.5% | 1,072,647 | 0.0% | 2.03% | +8.6% |
| Q2 2018 | $71,352,000 | +11.0% | 1,072,647 | +9.2% | 1.87% | +3.9% |
| Q1 2018 | $64,265,000 | +36414.2% | 982,647 | +9726.5% | 1.80% | +16263.6% |
| Q2 2015 | $176,000 | +1.1% | 10,000 | 0.0% | 0.01% | -21.4% |
| Q1 2015 | $174,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,909,742 | $911,991,000 | 16.68% |
| Vivo Capital, LLC | 1,797,745 | $277,428,000 | 16.03% |
| Sofinnova Investments, Inc. | 1,109,874 | $171,276,000 | 12.70% |
| Asymmetry Capital Management, L.P. | 81,442 | $12,568,000 | 8.08% |
| Ghost Tree Capital, LLC | 130,000 | $20,062,000 | 5.80% |
| Eversept Partners, LP | 161,004 | $24,846,137 | 5.52% |
| Eventide Asset Management | 1,709,848 | $263,864,000 | 5.16% |
| Avoro Capital Advisors LLC | 1,800,000 | $277,776,000 | 3.95% |
| BERYLSON CAPITAL PARTNERS, LLC | 72,700 | $11,219,000 | 3.93% |
| Spyglass Capital Management LLC | 547,022 | $84,416,000 | 3.90% |